Inventor
IBRAHIM PRABHA N
US97 patents
⚠️ This page may combine multiple inventors who share the name “IBRAHIM PRABHA N”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PLEXXIKON INC
33 patentsUS7893075B2Feb 22, 2011
Compounds modulating c-fms and/or c-kit activity and uses therefor
PLEXXIKON INC96 citations99
US9771363B2Sep 26, 2017
Heterocyclic compounds and uses thereof
PLEXXIKON INC34 citations98
US9487515B2Nov 8, 2016
Compounds modulating c-fms and/or c-kit activity and uses therefor
PLEXXIKON INC44 citations98
US9469640B2Oct 18, 2016
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC44 citations98
US9358235B2Jun 7, 2016
Kinase modulation, and indications therefor
PLEXXIKON INC41 citations98
US9260437B2Feb 16, 2016
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC100 citations98
US9169250B2Oct 27, 2015
Compounds modulating c-fms and/or c-kit activity and uses therefor
PLEXXIKON INC36 citations98
US8722702B2May 13, 2014
Compounds modulating c-fms and/or c-kit activity and uses therefor
PLEXXIKON INC60 citations98
US7947708B2May 24, 2011
Compounds modulating C-kit activity
PLEXXIKON INC52 citations98
US7863288B2Jan 4, 2011
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC187 citations98
US7846941B2Dec 7, 2010
Compounds modulating c-kit and c-fms activity and uses therefor
PLEXXIKON INC92 citations98
US7723374B2May 25, 2010
PPAR active compounds
PLEXXIKON INC54 citations98
US7498342B2Mar 3, 2009
Compounds modulating c-kit activity
PLEXXIKON INC80 citations98
US7491831B2Feb 17, 2009
PPAR active compounds
PLEXXIKON INC56 citations98
US7476746B2Jan 13, 2009
PPAR active compounds
PLEXXIKON INC61 citations98
US8367828B2Feb 5, 2013
PPAR active compounds
PLEXXIKON INC54 citations97
US7863289B2Jan 4, 2011
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC131 citations97
US7605168B2Oct 20, 2009
PDE4B inhibitors
PLEXXIKON INC62 citations97
US7572806B2Aug 11, 2009
PPAR active compounds
PLEXXIKON INC59 citations97
US7348338B2Mar 25, 2008
PPAR active compounds
PLEXXIKON INC79 citations97
US7202266B2Apr 10, 2007
PPAR active compounds
PLEXXIKON INC65 citations97
US7585859B2Sep 8, 2009
PDE4B inhibitors and uses therefor
PLEXXIKON INC67 citations96
US10370374B2Aug 6, 2019
Heterocyclic compounds and uses thereof
PLEXXIKON INC17 citations94
US9975894B2May 22, 2018
Heterocyclic compounds and uses thereof
PLEXXIKON INC20 citations94
US9814714B2Nov 14, 2017
Kinase modulation, and indications therefor
PLEXXIKON INC22 citations94
US9730918B2Aug 15, 2017
Kinase modulation, and indications therefor
PLEXXIKON INC25 citations94
US9718847B2Aug 1, 2017
Heterocyclic compounds and uses thereof
PLEXXIKON INC33 citations94
US9695169B2Jul 4, 2017
Synthesis of heterocyclic compounds
PLEXXIKON INC26 citations94
US9682981B2Jun 20, 2017
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC25 citations94
US9676748B2Jun 13, 2017
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC23 citations94
US9617267B2Apr 11, 2017
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC38 citations94
US9550768B2Jan 24, 2017
Kinase modulation and indications therefor
PLEXXIKON INC41 citations94
US9440969B2Sep 13, 2016
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC40 citations94
IBRAHIM PRABHA N
11 patentsUS8143271B2Mar 27, 2012
Compounds and methods for kinase modulation, and indications therefor
IBRAHIM PRABHA N124 citations99
US8912204B2Dec 16, 2014
Compounds and methods for kinase modulation, and indications therefor
IBRAHIM PRABHA N115 citations98
US8673928B2Mar 18, 2014
Compounds and methods for kinase modulation, and indications therefor
IBRAHIM PRABHA N60 citations98
US8642606B2Feb 4, 2014
ZAP-70 active compounds
IBRAHIM PRABHA N54 citations98
US8404700B2Mar 26, 2013
Compounds modulating c-fms and/or c-kit activity and uses therefor
IBRAHIM PRABHA N63 citations98
US8198273B2Jun 12, 2012
Compounds and methods for kinase modulation, and indications therefor
IBRAHIM PRABHA N65 citations98
US8158636B2Apr 17, 2012
Compounds and methods for kinase modulation, and indications therefor
IBRAHIM PRABHA N59 citations98
US8129404B2Mar 6, 2012
Compounds and uses thereof
IBRAHIM PRABHA N50 citations98
US8901301B2Dec 2, 2014
Pyrrolo[2,3-]pyridine kinase inhibitors
IBRAHIM PRABHA N52 citations97
US8470818B2Jun 25, 2013
Compounds and methods for kinase modulation, and indications therefor
IBRAHIM PRABHA N94 citations97
US8415469B2Apr 9, 2013
Compounds and methods for kinase modulation, and indications therefor
IBRAHIM PRABHA N84 citations97
CV THERAPEUTICS INC
4 patentsUS6573264B1Jun 3, 2003
Heteroaryl alkyl piperazine derivatives
CV THERAPEUTICS INC60 citations96
US6552023B2Apr 22, 2003
Aralkyl substituted piperazine compounds
CV THERAPEUTICS INC64 citations96
US6294522B1Sep 25, 2001
N6 heterocyclic 8-modified adenosine derivatives
CV THERAPEUTICS INC122 citations96
US6548548B2Apr 15, 2003
ABCA-1 elevating compounds
CV THERAPEUTICS INC61 citations95
ZHANG JIAZHONG
2 patentsShowing the top 50 of 97 patents by PatentIndex Score.